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Abstract
The last two decades have seen a worldwide resurgence in infections caused by Treponema 
pallidum subsp. pallidum, the syphilis spirochete. The syphilis spirochete’s well-recognized 
capacity for early dissemination and immune evasion has earned it the designation ‘the stealth 
pathogen’. Despite the many hurdles to studying syphilis pathogenesis, most notably the inability 
to culture and to genetically manipulate T. pallidum, in recent years, considerable progress has 
been made in elucidating the structural, physiologic, and regulatory facets of stealth pathogenicity. 
In this Review, we integrate this eclectic body of information to garner fresh insights into the 
highly successful parasitic lifestyles of the syphilis spirochete and related pathogenic treponemes.
Pathogenic treponemes cause venereal syphilis, yaws, endemic syphilis, and pinta—multi-
stage, infections that, although similar, can be differentiated based on clinical, 
epidemiologic, and geographic criteria1,2. Only venereal syphilis (see Box 1 for a detailed 
description) is transmitted by sexual activity. The pathogenic treponemes are uncultivatable, 
slow-growing microorganisms with identical flat-wave morphologies. They poorly tolerate 
desiccation, elevated temperature, and ambient oxygen tension, traits that explain why 
efficient transmission requires close personal contact1,2. Landmark DNA-DNA hybridization 
studies3,4 showed that DNA from a venereal syphilis spirochete (Nichols strain) shared less 
than 5% homology with DNA from cultivatable treponemes but was indistinguishable from 
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DNA of the yaws spirochete (Gauthier strain). This work led to the reclassification of the 
agents of venereal syphilis, endemic syphilis, and yaws as Treponema pallidum subspecies 
pallidum, endemicum, and pertenue, respectively. Genomic sequencing has established that 
these subspecies are clonal but form distinct genetic clusters with venereal syphilis strains, 
the most recently evolved group, likely diverging from the pertenue cluster several thousand 
years ago5. Genomic sequencing also has revealed that T. paraluiscuniculi (reclassified as 
Treponema paraluisleporidarum ecovar Cuniculus6), the cause of venereal spirochetosis in 
rabbits, shares a common ancestor with human pathogenic treponemes7. WHO estimates 
that ~90 million people in Africa, Asia and the Western Pacific currently are at risk for 
yaws8. Globally, ~11 million people acquired syphilis in 20089, with mother-to-child 
transmission occurring in nearly 2 million pregnancies10. T. pallidum is considered the most 
virulent subspecies because it routinely traverses blood-brain and maternal-fetal placental 
barriers11.
Box 1
Venereal syphilis in brief
After an incubation period ranging from 9 to 90 days, during which spirochetes are 
already blood-borne, disease commences with the appearance of the hallmark ulcerative 
lesion, the chancre (A (http://phil.cdc.gov) and B (courtesy of Kevin Dieckhaus11)), at the 
site of inoculation. Mucocutaneous lesions of secondary syphilis (C (with permission 
from Reference 27) and D (courtesy of Adriana Cruz and Juan Salazar)) appear 4 to 10 
weeks later. This stage is associated with the highest incidence of spirochetemia, the 
greatest treponemal burdens in blood and tissues, and the highest titers in serodiagnostic 
tests11. A pregnant woman with untreated secondary syphilis is at great risk of 
transmitting the disease to her fetus (E (http://phil.cdc.gov))28. Invasion of the central 
nervous system in as many as 40% of individuals with untreated early syphilis sets the 
stage for potentially devastating neurologic complications years later11. After weeks to 
months, the patient enters a period of latency during which, in the absence of a clinical 
relapse, the diagnosis can be made only by serologic testing. Latency is divided into early 
latent (infectious relapses and/or spirochetemia common) and late latent (relapses and/or 
spirochetemia unlikely) stages. Approximately 25% of patients will experience one or 
more secondary-like relapses during early latency, 90% of which occur in the first year. 
Approximately 30% of untreated patients will develop one of the recrudescent syndromes 
(‘benign’ gummas (F (http://phil.cdc.gov)), cardiovascular syphilis (G, aortic arch 
aneurysm), and neurosyphilis (H, right cerebellar infarct indicated by arrow, (http://
phil.cdc.gov)) collectively designated tertiary syphilis11.
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Venereal syphilis is acquired when treponemes are inoculated onto the mucosa or skin 
during sexual contact. Spirochetes directly penetrate mucous membranes or they enter 
through breaches in skin produced by sexual activity12. Attachment to host cells and the 
extracellular matrix is considered to be the crucial initial step of infection13,14. Once below 
the epithelium, the spirochetes multiply locally and disseminate through the lymphatics and 
the bloodstream12. T. pallidum’s flexuous, flat-wave morphology (Fig. 1A and B)15 enables 
it to penetrate tissues and vascular barriers throughout the body, while its periplasmic 
motility apparatus propels it forward via front-to-back undulations coordinated in response 
to poorly understood chemotactic signals16,17. Although it is not clear how T. pallidum 
benefits by invading deep visceral and musculoskeletal tissues, reaching and surviving in 
distal skin and mucosal sites enhances opportunities for subsequent transmission.
Venereal syphilis can be thought of as a contest between the ability of T. pallidum, generally 
considered to be an extracellular pathogen, to avoid recognition and the adeptness of the 
host’s innate and adaptive immune responses to ‘track down’ the pathogen12. The 
spirochete’s fragile outer membrane lacks lipopolysaccharide (LPS), the highly 
proinflammatory glycolipid found in Gram-negative bacteria18. Although T. pallidum 
expresses numerous lipoproteins capable of activating macrophages and dendritic cells 
(DCs) through Toll-like receptor (TLR) 2-dependent signaling pathways19, they are 
predominantly below the surface13. The paucity of surface-exposed pathogen-associated 
molecular patterns (PAMPs) enables the bacterium to undergo repeated bouts of 
dissemination that are poorly detected by innate immunity and also explains the lack of 
systemic inflammatory symptoms characteristic of the disease11. The appearance of opsonic 
antibodies, which promote internalization, killing, and degradation of spirochetes within 
phagolysosomes, represents a turning point in the battle between host and pathogen19–21. 
However, by liberating lipopeptides for binding to TLRs lining the interior of the phagosome 
and antigenic peptides for presentation to resident and locally recruited T cells, bacterial 
clearance and killing becomes a double-edged sword. The ensuing inflammatory response 
causes tissue damage that gives rise to clinical manifestations11. Spirochetes replicating in 
tissues elicit a complex and variable inflammatory cell infiltrate consisting of macrophages, 
CD4+ and CD8+ T lymphocytes, and plasma cells, accompanied by varying degrees of 
endothelial cell swelling and proliferation. Production of IFN-γ by locally activated CD4+ 
and CD8+ T cells enhances the capacity of macrophages to internalize and degrade 
spirochetes but also bolsters their output of potentially tissue damaging, proinflammatory 
cytokines22–26.
Importantly, spirochetes are not easily cleared by opsonic antibodies; in fact, during 
secondary and early latent syphilis, viable bacteria circulate despite high titers of anti-
treponemal antibodies27,28. How the pathogen burden is eventually decreased and latency 
established and maintained is a mystery. Passive immunization with sera from previously 
infected rabbits immune to rechallenge with T. pallidum suggests that antibodies play a 
critical role in suppressing spirochete burdens during latency29,30, although a contribution by 
cellular immunity cannot be ruled out19,31. Equally mysterious is where spirochetes reside 
during latency. Experiments in rabbits have suggested that T. pallidum may use hair follicles 
and nerves as protected niches32. T. pallidum’s capacity to survive for prolonged periods 
while hiding ‘in plain sight’ of humoral defenses represents its defining feature as a stealth 
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pathogen33. In the remainder of this Review, we integrate an eclectic and sometimes 
puzzling body of information to garner fresh insights into a fundamental question of syphilis 
pathogenesis: how does T. pallidum make a living in its obligate human host?
Experimental roadblocks and new directions
T. pallidum was among the first major bacterial pathogens of humans to be identified, yet 
our knowledge of syphilis pathogenesis lags well behind that of other common bacterial 
infections34. One of the main reasons for this is the syphilis spirochete’s refractoriness to 
cultivation in vitro, despite intensive efforts dating almost from its discovery in 190635. In 
the 1940s, investigators defined incubations conditions and medium components that 
maintained treponemal motility and virulence for 6–8 days, although without replication36. 
In the early 1980s, reproducible increases (20- to 100-fold) in replication, with full 
preservation of motility and virulence, were obtained by cultivating treponemes under 
microaerophilic conditions in the presence of cottontail rabbit epithelial (Sf1Ep) cells37,38. 
Subsequent efforts to improve on these results by meticulously defining growth conditions 
and parameters yielded new information about T. pallidum growth requirements but only 
modest increases in replication without achieving continuous culture35,39. Although the 
genomic sequence confirmed that T. pallidum depends upon its host for virtually all of its 
nutritional requirements18, it did not yield obvious, untried solutions to the cultivation 
problem35. A contemporary bioinformatics-based analysis of the possible functions of the 
more than 400 ‘hypothetical’ proteins encoded in the T. pallidum genome40 may inform 
future attempts. Recent recognition of the importance of riboflavin uptake and flavin 
utilization for spirochete metabolism and energy generation may be pertinent as well41,42. 
Therefore, investigators today still rely upon intratesticular inoculation of rabbits to isolate 
T. pallidum strains from clinical samples and propagate them for experimentation43.
The once popular notion that T. pallidum’s poor surface antigenicity can be attributed to a 
pseudo-capsule of serum proteins and mucopolysaccharides44 gave way in the early 1990s to 
overwhelming evidence that the bulk of its immunogenic molecules are subsurface and that 
its delicate outer membrane forms the protective barrier13,45. Despite the formidable 
roadblock imposed by the cultivation barrier, compounded by the lack of a facile, inbred 
animal model for assessing protective immunity46, our understanding of this unorthodox 
bacterial outer membrane and its interactions with host defenses has increased substantially 
in recent years13,47. In parallel, there has been growing interest in the physiologic and 
regulatory foundations of stealth pathogenicity. Residence in a rich, relatively homeostatic 
environment has enabled T. pallidum to dispense with genes for de novo synthesis of 
nucleotides, fatty acids, vitamins, co-factors, amino acids, the tricarboxylic acid cycle, and 
oxidative phosphorylation18, resulting in the smallest of the spirochete genomes (~1.1 MB) 
and one of the smallest among pathogenic bacteria48. During the course of genomic 
reduction, the bacterium has undergone remarkable adaptations that enable it to acquire all 
of its required nutrients and optimize their usage within diverse niches, while coping with 
exogenous and endogenous stress.
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The face of stealth-the outer membrane
Studying the properties and composition of the outer membrane of T. pallidum has been, and 
remains, arduous13,45. The quest for rare outer membrane proteins (OMPs) began in earnest 
with the discovery by freeze-fracture electron microscopy (Fig. 1C), recently confirmed by 
scanning probe microscopy (Fig. 1D), that T. pallidum contains ~100-fold fewer OMPs than 
Escherichia coli49,50. How then does T. pallidum meet its nutritional requirements and carry 
out its complex parasitic lifestyle with a minimalist outer membrane? A partial answer may 
lie with the bacterium’s slow (~30 h) rate of replication51, presumably an evolutionary 
‘compromise’ between the density of OMPs needed for viability and the demands of stealth.
Tpr proteins
Little progress identifying rare OMPs was made until the genomic sequence revealed the 
existence of the T. pallidum repeat (Tpr) proteins, a 12 member paralogous family with 
sequence homology to the major outer sheath protein (MOSP) of Treponema 
denticola18,52,53, which is a known pore-forming protein and adhesin54. Of these, TprK 
(TP0897)21,52,55 has received the greatest attention because of its proposed role in immune 
evasion (see below), although its status as a bona fide OMP has been challenged56,57. Except 
for BamA (TP0326, originally known as TP9258), the T. pallidum genome does not encode 
proteins with a high degree of sequence homology to well-characterized OMPs of Gram-
negative bacteria18. As an alternative to genome mining for OMP orthologs, we used a 
computational matrix to identify proteins predicted to adopt the hallmark conformation of an 
OMP, the β-barrel57. The two highest ranked Tprs, TprC/D (TprC (TP0117) and TprD 
(TP0131) are identical in the Nichols strain) and TprI (TP0620), possess all of the properties 
expected of a rare OMP59,60. The native proteins are low in abundance (~200 copies per 
cell), surface-exposed, and amphiphilic, whereas the folded recombinants form β-sheet-rich, 
heat-modifiable trimers that readily insert into artificial membranes. Similar to MOSP61, 
integration of TprC/D and TprI into liposomes results in permeability increases comparable 
to those produced by the archetypal porin, E. coli OmpF59,60. Formation of large, non-
selective channels could explain how these rare proteins function cooperatively to meet the 
spirochete’s nutritional needs. With classical porins, the entire polypeptide forms the β-
barrel62; a pivotal discovery is that TprC/D and TprI are bipartite (Fig. 1E)59,60. A C-
terminal domain forms the β-barrel, while the N-terminal portion extends into the periplasm, 
anchoring the barrel to the murein sacculus. Consistent with this bipartite model, TprF, a 
truncated TprC/D/I ortholog of these Tprs lacking the C-terminal β-barrel domain, is 
periplasmic. Of note, these analyses provide a functional and topological template for the 
extended Tpr family61,63.
BamA and outer membrane biogenesis
Among the non-Tpr proteins predicted to form β-barrels57, BamA is of paramount 
importance. BamA is the essential central component of the β-barrel assembly machine 
(Bam) that catalyzes the insertion of newly exported OMPs into the outer membrane64,65. 
Like other members of the Omp85 superfamily, BamA has a dual domain architecture 
consisting of an outer membrane-inserted, C-terminal β-barrel and periplasmic polypeptide 
transport-associated (POTRA) repeats (in this case, five, Fig. 1E)64,65. As in other bacteria, 
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BamA in T. pallidum is part of a complex (~400 kDa) whose subunits, unidentified thus far, 
assist in the insertion process64. Conceivably, the periplasmic chaperones Skp (TP0327) and 
SurA (TP1016), which ferry newly exported OMPs to the Bam apparatus66, function 
together with the POTRA repeats as a gatekeeper that regulates the protein composition and 
content of the outer membrane. A homology model based upon the solved structure of 
Neisseria gonorrhoeae BamA67 predicted that T. pallidum BamA contains a 16-stranded β-
barrel in which short, weakly hydrogen-bonded β1 and β16 strands separate to allow lateral 
insertion of nascent OMPs into the outer membrane65. The BamA barrel has eight 
extracellular loops, with three (L4, L6 and L7) forming a dome that occludes the barrel’s 
extracellular opening, directing nascent OMPs laterally into the bilayer. Although much of 
the dome is poorly immunogenic, L4 contains a surface-exposed, immunodominant, opsonic 
epitope, a potential Achilles’ heel likely imposed by functional constraints on the β-barrel.
Adhesins
In vitro studies well predating the genomics era demonstrated that T. pallidum can bind to a 
variety of mammalian cell types68,69 as well as extracellular matrix proteins, particularly 
laminin and fibronectin68,70. Using bioinformatics to identify potential outer membrane 
proteins in combination with binding assays, potential adhesins for fibronectin (TP0155 and 
TP0483)71 and lamin (TP0751) were identified72,73. In addition to being an adhesin, TP0751 
is a zinc-dependent metalloprotease (hence, was named “pallilysin”) that forms a complex 
with TP0751 (which contains a Von Willebrand factor type A domain) capable of degrading 
clots and extracellular matrix, which could facilitate both dissemination and attachment74,75. 
The lipoprotein TP0136 is a fibronectin-binding adhesin with sequence heterogeneity among 
T. pallidum strains (Table 1)76,77. Most recently, elegant gain of function experiements using 
B. burgdorferi as a surrogate genetic host have shown that the lipoprotein TP0435 (Tpp17) 
functions as a cytadhesin 78.
Implications for limiting surface antigenicity
While there is consensus that resistance to antibody binding is the basis for immune evasion 
by T. pallidum12,55, much remains to be learned about how the pathogen accomplishes this 
impressive feat and, conversely, the counter-measures used by the host. Early 
immunolabeling experiments suggested that the outer membrane of T. pallidum is 
antigenically inert79,80. However, this simplistic notion is contradicted by biological assays 
showing that syphilitic infection does, in fact, induce antibodies that react with the bacterial 
surface19. Moreover, immunolabeling and opsonophagocytosis assays have revealed that T. 
pallidum populations are heterogeneous, consisting of antibody-binding and non-binding 
subpopulations, and that organisms that bind antibodies do so with markedly slow 
kinetics26,57,81. These observations likely explain the longstanding paradox that clearance 
and persistence of T. pallidum occur simultaneously26. At a given site, antibody binders 
would be slowly cleared, also ‘feeding’ inflammation, whereas immunoevasive non-binders 
would replicate locally and disseminate systemically.
How, then, does heterogeneity in surface antigenicity occur? With BamA, TprC/D, and TprI, 
the large majority of antibodies are directed against periplasmic domains60,64,65 and, are, 
therefore, ineffective for clearance. For those antibodies that are potentially opsonic, the 
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extremely low copy numbers of the target proteins likely limits their accessibility, as 
evidenced by the sizable percentage of treponemes that fail to become surface-labeled or 
opsonized by high-titer recombinant antisera against TprC/D or BamA59,65. Similarly, recent 
studies suggest that the TP0750–TP0751 protease complex74,75 and TP043578 are expressed 
at low levels on the surfaces of some treponemes and, consequently, of limited availablity to 
antibody binding. Two distinct mechanisms for modulating antibody reactivity with Tprs 
have been proposed. TprK undergoes sequence and antigenic variation in seven 
hypervariable regions, B-cell epitopes proposed to be located in external loops, through gene 
conversion from a donor site located elsewhere on the chromosome55,82–86. Recent 
resequencing of the genome of strain SS14 has revealed sequence heterogeneity within the 
β-barrel-encoding portion of TprD (TP0131)87, suggesting that this OMP also undergoes 
antigenic variation. A second mechanism pertains to TprE, TprG and TprJ; changes in the 
number of G nucleotide repeats immediately upstream of their transcriptional start sites, due 
to slipped strand mispairing during DNA replication, influences the amount of message 
produced88. Unquestionably, much more investigation, including far better characterization 
of T. pallidum’s entire OMP repertoire and individual surface molecules, is needed before 
the pieces of this complex puzzle come together.
What lays beneath
Cell envelope structure
The architectural plan for the cell envelope of T. pallidum differs substantially from that of 
Gram-negatives89. Images obtained by conventional transmission electron microscopy of 
fixed, embedded organisms showed the outer and cytoplasmic membranes juxtaposed with 
the peptidoglycan layer sandwiched between90. However, visualization of the cell envelope 
in its native state by cryoelectron tomography15,91 revealed that the two membranes are 
actually well separated with a thin peptidoglycan layer creating two distinct zones within the 
periplasmic compartment (Fig. 1F). The lower, denser zone contains the periplasmic 
domains of integral proteins of the cytoplasmic membrane (various permeases), and the 
polypeptide moieties of lipoproteins, many of which are substrate-binding proteins (SBPs) 
for ABC transporters (Fig. 1E). Near the cell poles are chemoreceptor arrays containing the 
T. pallidum’s four methyl-accepting chemotaxis proteins (Mcp1 (TP0040), Mcp2 (TP0488), 
Mcp3 (TP0639) and Mcp4 (TP0640)) (Fig. 1G)91, sensors that bind exogenously derived 
ligands within the periplasm and relay chemotactic signals to the more distal flagellar 
motors92. A cone-like lattice at the cell tips, connected by fine fibrils to the outer membrane, 
could function as an organelle mediating end-on attachment (Fig. 1H)15,91. The proximity of 
this tip structure to the flagellar motors and chemoreceptor arrays theoretically enables close 
coordination between attachment, environmental sensing and directed motility. By providing 
receptors distributed along the length of the cell body, the aforementioned adhesins would 
enable organisms to gain an initial ‘foothold’ before becoming stably attached at their tips.
Transport across the cytoplasmic membrane
T. pallidum uses diverse ABC transporters and symporters (totaling ~5% of its genome) to 
transfer molecules required for cell viability from periplasm to cytosol (Fig. 1E, also see 
TransportDB, http://membranetransport.org/). Following passive diffusion of glucose across 
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the outer membrane through nonselective porins, the methylgalactoside (Mgl) glucose-
galacatose ABC transporter (consisting of TP0545 and TP0684-0686) is believed to mediate 
high-affinity transport across the cytoplasmic membrane93. Consistent with its lack of 
biosynthetic capacity, T. pallidum seems to possess a broad, though not easily understood, 
transporter repertoire for amino acids. One ABC transporter, MetI-MetN-MetQ (TP0119-
TP0120-TP0821 (also known as TpN32)) is dedicated to the uptake of methionine94. The 
genome encodes three other putative SBPs with predicted specificities for oligopeptides 
(OppA (TP0585)), histidine (HisJ (TP0308)) and polar amino acids (TP0309), but their 
corresponding permeases and ATP-binding proteins have yet to be identified. Rounding out 
the T. pallidum’s amino acid requirements are putative symporters for aspartate and 
glutamate (TP0555 and TP0934), alanine and glycine (TP0414 and TP0998) and branched 
chain amino acids (TP0265). In addition, TP0144 functions as the SBP for a thiamine ABC 
transporter (TbpAPQ(TP0142-0144))95. BioMNY (TP0226-0228), a putative biotin 
importer, seems to be the bacterium’s only energy coupling factor (ECF)-type ABC 
transporter96.
Structural biology has become an essential tool for studying cell envelope constituents of T. 
pallidum. The crystal structure of TroA (TP0034), originally thought to be a rare OMP, 
revealed that it belonged to a newly discovered class of SBPs associated with transition-
metal ABC transporters97. Crystallography and binding studies showed TmpC (TP0319) to 
be the SBP for the first ABC-type purine nucleoside transporter system (PnrABCDE 
(TP0319-323)) described in any bacterium98. Another lipoprotein, TP0655, was shown to be 
the SBP for a polyamine transporter (PotABCD (TP0652-0655)) with nanomolar binding 
affinities for putrescine and spermidine99. The X-ray structure of TP0298, also a lipoprotein, 
revealed it to be the SBP of a riboflavin transporter (RfuABCD (TP0298-0302))41 which 
collaborates with a dual function FAD pyrophosphatase-FMN transferase (Ftp 
(TP0796))42,100 to meet the T. pallidum’s prodigious requirements for flavin cofactors. A 
longstanding question has been how T. pallidum, a fatty acid auxotroph, obtains essential 
long-chain fatty acids (LCFAs). Recent structural analyses have led to the description of a 
multimeric lipoprotein complex (/TatT-TatP (TP0956–TP0957)) thought to comprise a 
tetratricopeptide repeat (TPR)-protein associated transporter that traffics LCFAs across the 
periplasm101,102.
Carbohydrate utilization and energy generation
Access to a plentiful supply of glucose in blood and interstitial fluids almost certainly 
explains why T. pallidum can rely on glycolysis as its primary means for generation of ATP 
(Fig. 2). In line with this notion is the lack of a complete pathway for gluconeogenesis and 
the inability to β-oxidize fatty acids and catabolize amino acids18. Telling in terms of the 
importance of glucose for driving T. pallidum’s ‘engine’ are classic studies showing rapid 
loss of motility upon glucose deprivation and rapid resumption of motility with it 
restored103. Whether T. pallidum needs alternative carbon sources is unclear. In contrast to 
Borrelia burgdorferi, the Lyme disease spirochete104, T. pallidum lacks genes for importing 
and utilizing exogenous glycerol, instead using glycerol phosphate dehydrogenase (GpsA 
(TP1009)) to convert dihydroxyacetone phosphate to glycerol-3-phosphate for phospholipid 
synthesis18. It also lacks phosphoenolpyruvate (PEP)-dependent phosphotransferase system 
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(PTS) permeases (a ubiquitous means among bacteria for importing and regulating uptake of 
alternative sugars105), relying, instead, on hexokinase to phosphorylate glucose as the first 
step in glycolysis18. Bioinformatics, however, predict at least one additional ABC sugar 
permease (TP0075–TP0076), which uses two different SBPs (TP0074 and TP0737) and a 
nucleotide ATP-binding subunit, TP0804, an ortholog of E. coli MalK18. The functionality 
of this putative multiple sugar transporter is supported by the observation that, in addition to 
glucose, maltose and mannose can support replication of T. pallidum in vitro35.
Some clever modifications in the conventional glycolytic pathway, shared with 
phylogenetically diverse organisms (eubacteria, protozoa, and plants106), enable T. pallidum 
to extract as much energy as possible from substrate level phosphorylation while enhancing 
metabolic versatility (Fig. 2). To spare ATP, T. pallidum uses a phosphofructokinase 
employing pyrophosphate (PPi-PPFK (TP0542)) instead of the ATP-dependent enzyme 
(ATP-PPFK)107; B. burgdorferi, also glycolysis-dependent, uses an orthologous enzyme108. 
Moreover, whereas ATP-PPFK is irreversible and a major point for allosteric regulation of 
standard glycolysis109, PPi-PFK is reversible and non-allosteric107. A second modification is 
the substitution of the reversible pyruvate phosphate dikinase (PPDK (TP0746)) for pyruvate 
kinase18,108. When coupled to adenylate kinase (TP0595), PPi-PPDK yields four ATPs per 
glucose compared with the two from pyruvate kinase in standard glycolysis110. The 
reversibility of the PPDK reaction, in concert with PEP carboxykinase (PEPCK (TP0122)), 
and oxaloacetate decarboxylase (OadA-OadB (TP0056–TP0057), creates a cycle for inter-
conversion of pyruvate, PEP and oxaloacetate. PEP likely is central for T. pallidum to sense 
and regulate carbon and nitrogen flux (Box 2). T. pallidum can use oxaloacetate for its 
limited amino acid metabolism through conversion to aspartate by aspartate 
aminotransferase (TpaaT (TP0223)), with glutamate as the amine donor, and subsequently to 
asparagine by asparagine synthetase (AsnA (TP0556)). T. pallidum produces another ATP 
by converting pyruvate to acetate by pyruvate-flavodoxin oxidoreductase (PFOR (TP0939)), 
acetate kinase (AckA (TP0476)) and phosphate acetyl transferase (Pta (TP0094)). 
Importantly, whereas the more common pyruvate dehydrogenase reduces NAD+ to NADH, 
the electrons released by PFOR during oxidative decarboxylation of pyruvate are transferred 
to a low potential single electron carrier, probably flavodoxin (TP0925), which, as noted 
below, may then transfer them to a newly discovered pathway for chemiosmotic energy 
conservation.
Box 2
A chimeric PTS for control of carbon and nitrogen metabolism
Although T. pallidum has access to a continuous supply of nutrients, their availability and 
proportions likely vary in different niches. The phosphoenolpyruvate (PEP)-dependent 
phosphotransferase system (PTS) appears to be the spirochete’s primary mechanism for 
adjusting carbon and nitrogen utilization. Two general types of PTS have been described: 
a canonical PTS dedicated to carbohydrate utilization and a nitrogen-related PTS 
(PTSNtr) that is exclusively regulatory105,147. Because T. pallidum lacks PTS permeases, 
its PTS must be solely regulatory. However, it is also chimeric, combining elements 
derived from the sugar PTSs of Gram-negatives (Enzyme I (EI (TP0575)) and histidine 
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phosphocarrier protein (Hpr (TP0589)) and Gram-positives (Hpr kinase (HprK (TP0591)) 
with the PTSNtr-derived components EIIANtr-1 (TP0085) and EIIANtr-2 (TP0755)105,148. 
The resulting hybrid seems capable of intricate metabolic control. Although EI and HprK 
both phosphorylate Hpr, they do so at different sites: E1 at His-15 (the catalytic site) and 
HprK at Ser-46 (the regulatory site), with PEP and ATP as the respective phosphoryl 
donors149,150. Since phosphorylation at one site inhibits phosphorylation at the other, the 
activities of EI and HprK seem counter-regulatory. Recalling the inter-conversion of PEP 
and aspartate through oxaloacetate described earlier, one can envision how cross-talk 
between the EI and HprK-Hpr pathways might regulate carbon-nitrogen flux; our 
proposed scheme is based on Saier’s postulate that the HprK-Hpr pathway is the direct 
regulator of glycolysis in treponemes151. When amino acids are relatively scarce, 
glycolysis would have to furnish substrate for their production in addition to meeting the 
cell’s energy needs. The resulting drain on PEP would diminish phosphorylation of Hpr 
at His-15 by EI, leading to enhanced glycolysis driven by HprK-Hpr. When amino acids 
are plentiful, the flow would be reversed, and aspartate would be converted to PEP, 
promoting the EI pathway and antagonizing phosphorylation of Hpr at Ser-46 by HprK.
In Gram-positives, Hpr(Ser)-P activates catabolite control protein A (CcpA), the 
transcription factor responsible for carbon catabolite repression105. T. pallidum does not 
contain this regulatory protein, so the effector molecule(s) influenced by the Hpr-HprK 
pathway is unknown. In E. coli, dephosphorylated EIIANtr broadly influences metabolism 
by regulating intracellular potassium levels through its interactions with the potassium 
transporter Trk152, which T. pallidum possesses. Interacting partners of phosphorylated 
EIIANtrs have not been identified in any bacterium153. Given the elements T. pallidum 
has appropriated from the sugar PTS, one possibility is that one or both phosphorylated 
EIIANtrs activate adenylate cyclase (TP0485)105. Although admittedly without precedent, 
it is important to note that TP0485 belongs the largest and most diverse group of 
adenylate cyclases, Class III, whereas the extensively studied E. coli enzyme belongs to 
Class I154. This has provocative implications given T. pallidum’s four predicted cAMP-
binding proteins (TP0089, TP0261, TP0262, and TP0095) and the well-established link 
between production of cAMP and bacterial virulence154.
Besides depriving T. pallidum of the full energy content of glucose, the absence of oxidative 
phosphorylation creates two metabolic quandaries: (i) how to regenerate NAD+ from NADH 
in order to maintain glycolysis and (ii) how to generate the electrochemical potential across 
the cytoplasmic membrane that is needed to drive the flagellar motor and nutrient uptake by 
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symporters. T. pallidum uses lactate dehydrogenase (LDH (TP0037)) and the flavoprotein 
NADH oxidase-2 (NOX-2 (TP0921)) to resolve the first dilemma (Fig. 2)111,112. Under low 
oxygen conditions, such as on mucosal surfaces, conversion of pyruvate to lactate by LDH 
predominates. In aerobic environments, NOX-2 uses NADH as the electron donor to reduce 
molecular oxygen to water. Once in the presence of oxygen, lactate generated under 
anaerobic conditions can be reclaimed as pyruvate, with NOX-2 regenerating NAD+ from 
the resulting NADH. Thus, NOX-2 serves a dual purpose: it promotes production of acetate 
from pyruvate and protects against oxygen toxicity. Reliance on NOX-2 likely accounts for 
the observation that T. pallidum, once considered an anaerobe because of its exquisite 
sensitivity to ambient oxygen concentrations, actually requires 3–5% O2 for optimal 
replication35,113, values closely matching those within mammalian tissues114. To resolve the 
second dilemma, with the added dividend of boosting energy production, T. pallidum is 
believed to couple the generation of an electrochemical gradient by a non-canonical flavin-
dependent Rhodobacter nitrogen fixation (Rnf) Na+/H+ redox pump to ATP synthesis by one 
or both of its A-type ATP synthases (formerly annotated as V-type ATPases) (Fig. 2)42,115. 
Transfer of electrons from reduced flavodoxin, generated by PFOR, drives the electrogenic 
pump115 with NAD+, generated by LDH or NOX-2 depending upon oxygen availability, the 
ultimate electron acceptor.
Transition metals and redox stress
Transition metal uptake
Although lacking many well-characterized bacterial metalloproteins, genome mining and 
biochemical studies have clearly established that T. pallidum requires all three transition 
metals—(iron, manganese and zinc) to fulfill vital structural and catalytic functions116,117; 
in fact, the recent identification of multiple Fe-S cluster proteins indicates a greater need for 
iron than previously recognized. Characteristically, T. pallidum seems to use arcane 
strategies to wage the battle for transition metals117. It cannot synthesize siderophores and 
does not possess a TonB ortholog for energizing transport across the outer membrane. It can 
extract iron from surface-bound lactoferrin and transferrin118, but the receptors are 
unknown. TpD (TP0971), a 34-kDa lipoprotein avidly binds human lactoferrin but is 
periplasmic119, and, therefore, cannot be functionally analogous to TbpB, the Neisseria 
gonorrhoeae lipoprotein co-receptor for lactoferrin120. Ferriportin-mediated efflux of soluble 
Fe2+ from host cells,121 with subsequent diffusion across the outer membrane, might bybass 
the need for TonB-dependent uptake in some tissues. Whereas many pathogens possess 
highly redundant systems for transport of transition metals across the cytoplasmic 
membrane, T. pallidum seems to accomplish this task with just two ABC transporters: Tro 
(transport-related operon), which can import iron, manganese, and zinc, and the zinc-
dedicated Znu116,122. Import of iron across the cytoplasmic membrane may be 
complemented by TP0972, a member of the iron permease Ftr1 superfamily119,123,124. A 
final metal-related oddity is T. pallidum’s ostensible lack of a global, transition metal-
dependent transcriptional regulator. The tro operon encodes a zinc- and/or manganese-
responsive DtxR-like repressor, TroR, which has no predicted binding sites outside of the tro 
promoter116,125.
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Dealing with oxidative stress
Because T. pallidum lacks many of the anti-oxidant enzymes common to other bacteria, its 
defenses against oxidative stress were long obscure, even with the availability of the 
genomic sequence. As information on novel anti-oxidant proteins in bacteria has grown in 
recent years, it has been possible to elucidate T. pallidum’s redox defense 
mechanisms117,126. Instead of a classical superoxide dismutase, T. pallidum uses two iron-
active center proteins, superoxide reductase (TP0823) and its reductant rubredoxin 
(TP0991), both acquired from hyperthermophilic anaerobes by a free-living ancestor,127 to 
protect against O2•−. The presence of these and other iron-containing proteins creates the 
need to carefully regulate intracellular iron stores to minimize iron-catalyzed production of 
protein-damaging and DNA-damaging hydroxyl radicals128. T. pallidum accomplishes this 
using the dps gene product TpF1 (TP1038), a dodecameric bacterioferritin with ferroxidase 
activity that binds soluble cytosolic Fe2+ and sequesters it as insoluble Fe3+ 129. For defense 
against peroxides, the bacterium depends upon a single robust, broad-spectrum, NADPH-
dependent peroxiredoxin, the flavoprotein alkyl hydroperoxide reductase C (TpAhpC 
(TP0509))130. In other bacteria, AhpC-like peroxidredoxins are recycled by a dedicated 
flavoprotein disulfide reductase, alkyl hydroperoxide reductase F (AhpF). T. pallidum not 
only lacks this enzyme, its TpAhpC has diverged from other AhpCs to the extent that it 
cannot use AhpF as an electron donor; it relies instead on thioredoxin (TrX (TP0919)) and 
thioredoxin reductase (TrxR (TP0814))130. Both TpAhpC and TpTrx are expressed at very 
high levels in spirochetes freshly harvested from rabbit testes130, suggesting that peroxides 
are a major form of oxidative stress encountered during infection. TxR and TrxR presumably 
do double-duty defending against disulfide stress, although the low molecular weight, 
primary thiol redox buffer remains unidentified. Also unclear is how, without known redox 
regulatory proteins (for example, OxyR, SoxR, and PerR), the bacterium senses oxidative 
stress, although in vitro studies indicate it has the capacity to do so130. The degree of 
disulfide bonding between TpF1131 and Tpp17132 monomers may serve as non-
transcriptional means for redox sensing in the cytosol and periplasm, respectively.
Regulation of gene expression
Unlike most pathogens and all environmental bacteria, T. pallidum does not contain two-
component systems that mediate large shifts in gene expression in response to alterations in 
growth conditions18,133. On the other hand, in addition to a σ70 housekeeping sigma factor 
(RpoD (TP0493)), the T. pallidum genome encodes four annotated alternative sigma factors, 
σE (RpoE (TP0092)), σ54 (RpoN (TP1011)), σA (TP1012), and σ28 (RpoF (TP0700)), 
collectively indicating a capacity to re-direct gene transcription in response to specific 
environmental cues. While σ28 presumably transcribes flagellar genes, T. pallidum deviates 
from traditional flagellar biosynthesis pathways in that it lacks an ortholog for FlhDC, the 
master transcriptional regulator for class II flagellar genes, and its σ28 gene lacks an 
upstream binding site for σ54 134. Also notably absent is the alternative sigma factor (σ32) 
that mobilizes a heat shock response, likely accounting for T. pallidum’s sensitivity to supra-
physiologic temperatures135. Furthermore, the genome encodes an unusual hybrid PTS 
system that putatively links carbon and nitrogen flux to gene regulation through the small 
nucleotide messenger cAMP (Box 2). The c-di-GMP signaling pathway is associated with a 
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wide range of adaptive processes and behaviors in other pathogenic bacteria136. The 
presence of this pathway in T. pallidum is, therefore, a potentially important discovery. 
According to bioinformatics, T. pallidum contains two diguanylate cyclases for synthesizing 
c-di-GMP (TP0172 and TP0981)136, three phosphodiesterases for degrading it (TP0764, 
TP0877, and TP0912), and a putative effector protein (TP0086), which contains a c-di-
GMP-binding PilZ domain40,136.
The susceptibility of the T. pallidum outer membrane to chemical and physical perturbations 
in vitro13,45 implies the need for a sensitive and robust system for sensing and responding to 
cell envelope stress in vivo. The σE (TP0092) pathway fulfills this function (Fig. 3A)137. 
tp0092 is highly transcribed during experimental syphilis,138 suggesting that σE-dependent 
genes are strongly induced by the inflammatory milieu in the rabbit testis. T. pallidum’s 
pathway for regulation of σE includes DegS (TP0773), RseP (TP0600), and RseA (TP0093) 
orthologs137. Notably absent is an identifiable ortholog for RseB, a negative regulator that 
binds to RseA and protects it from DegS-mediated cleavage137.
To initiate transcription, members of the σ54 family of alternative sigma factors recognize a 
unique -24/-12 type promoter and require hydrolysis of ATP by an enhancer-binding protein 
(EBP) that binds to an upstream sequence139,140. Further, interrogation of the T. pallidum 
genome for genes potentially transcribed by σ54 revealed tpf1 as the strongest candidate σ54-
dependent gene18. The genome also encodes two EBPs, the nitrogen regulatory protein C 
(NtrC)-like TP0519 and the nitric oxide reductase regulator (NorR)-like TP0082 (Fig. 3B)18. 
TP1012, annotated as an ortholog of the Gram-positive housekeeping σ factor (σA)18, 
presents an interesting conundrum. It seems unlikely that T. pallidum would have two 
housekeeping sigma factors. However, TP1012 is also a distant relative of E. coli σS (RpoS); 
moreover, inspection of the tp1012 sequence identified an ATG translational start with an 
excellently placed σ54 promoter. Thus, T. pallidum might harbor an EBP-σ54-σS cascade 
(Fig. 3B) mirroring the virulence-related Rrp2-σ54-σS pathway in B. burgdorferi141,142.
Comparative Genomics
The overall level of genetic identity among the human pathogenic treponemes, > 99.8%, 
implies that differences in virulence, invasiveness, and tissue tropisms arise from changes in 
a relative handful of genetic loci5,143,144. Table 1 lists the strongest candidate proteins 
potentially responsible for phenotypic differences between pallidum and pertenue 
subspecies. Of the 22 genes listed, 15 encode proteins known or believed to reside in the cell 
envelope, with members of the Tpr family particularly well represented. Many of the amino 
acid substitutions in the Tprs are located in the C-terminal domains known or predicted to 
form outer membrane-inserted β-barrels (Fig. 4). Strikingly, the tprA and tprF loci, which 
typically encode frame-shifted truncated proteins in venereal syphilis spirochetes, encode 
full-length proteins in pertenue strains63,143,145; the pertenue TprF β-barrel is TprI-like 
whereas the TprA barrel is unique (Fig. 4). The list in Table 1 also contains most of the 
candidates for differences between subspecies pallidum strains. The Tpr repertoires among 
venereal syphilis spirochetes (Fig. 4) are, on the whole, very similar, although sequence 
variation in known or potential β-barrel forming domains does occur (e.g., TprC, TprD, and 
TprI ), along with insertions (e.g., TprG and TprJ), sporadic truncations (e.g., TprG in 
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Seattle 81–4) or replacement of typically truncated proteins with full-length paralogs (for 
example, TprA, also in Seattle 81–4)145.
Structural homology modeling of BamA has afforded valuable insights into sequence 
differences revealed by genomics65. Mexico A-like strains have BamA β-barrels in which a 
single amino acid substitution in the immunodominant L4 surface loop markedly reduces 
reactivity of sera from patients infected with strains containing Nichols-like β-barrels65,146. 
Petrosova et al.146 made the seminal observation that the β-barrel in Mexico A TP0326 is 
identical to that in pertenue strains. They proposed that the pertenue TP0326 β-barrel was 
introduced into the subsp. pallidum genome as a result of recombination in an individual co-
infected with yaws and venereal syphilis. Since this L4 epitope is a prime opsonic target65, 
the resulting strain theoretically would be less susceptible to pre-existing Nichols anti-L4 
antibodies and, thus, capable of spreading in populations in which Nichols-like strains 
predominate.
Concluding remarks
Winston Churchill’s description of the Soviet Union as “a riddle, wrapped in a mystery, 
inside an enigma” could easily have been applied to T. pallidum. For decades, investigators 
obsessed with understanding protective immunity in syphilis pursued their Holy Grail, a 
syphilis vaccine, but were stymied by the ‘black box’ of the spirochete’s surface. 
Syphilologists now have in hand authentic OMPs and the experimental tools needed to 
establish authenticity for other candidates. These proteins also will enable clarification of the 
immunologic cat and mouse game that characterizes human syphilis and formulation of 
strategies to tease apart the virulence properties of the pathogenic treponemes. A relatively 
recent development in syphilis pathogenesis research has been the recognition that stealth 
pathogenicity has complicated and surprisingly obscure underpinnings that warrant intensive 
investigation. This Review underscores a theme now taking shape: the spirochete’s genomic 
reductionism, rather than being simply a matter of jettisoning unneeded genes, stems from a 
far more complicated evolutionary process, combining ultrastructural and metabolic 
parsimony with regulatory intricacy. Two forces appear to be at work: one is the need for T. 
pallidum to make the most of the nutrients it can usurp from its host, the other is the 
bacterium’s need to adapt to a diversity of micro-environments and stresses encountered 
during its journey within the human body. One of the great challenges to understanding 
these forces will be developing strategies to move beyond the static picture that has been an 
inadvertent byproduct of studying spirochetes extracted from a single milieu — the inflamed 
rabbit testis — to one that is dynamic and integrative.
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Glossary terms
Toll-like receptor (TLR) 2
A pattern recognition receptor that recognizes a variety of pathogen-associated molecular 
patterns, including bacterial lipoproteins.
Opsonic antibodies
Antibodies directed against a pathogen’s surface-exposed epitopes that bind to Fc receptors 
on a phagocytic cell, triggering internalization through phagocytosis.
Permease
A polytopic integral membrane protein that mediates energy-dependent uptake of small 
molecules across the plasma membrane of Gram-positives and the cytoplasmic membrane of 
Gram-negative bacteria.
ABC Transporter
An ATP-binding cassette transporter couples hydrolysis of ATP to transport (usually import) 
of a substrate across the cytoplasmic membrane of Gram-negative bacteria and the plasma 
membrane of Gram-positive bacteria. Classical bacterial ABC transporters have a modular 
composition consisting of a substrate-binding protein, a dimeric membrane-bound permease, 
and a dimeric nucleotide binding protein with ATPase activity.
Symporter
Transporter molecules that use the sodium or electrochemical gradient across the 
cytoplasmic membrane to drive the co-directional importation of substrates from the 
periplasmic to the cytosolic compartment.
Auxotroph
An organism that has lost the ability to synthesize molecules required for growth. T. 
pallidum is considered an extreme auxotroph because of its very limited biosynthetic 
capacity.
Two-component system
Two-component systems typically consist of a membrane-bound histidine kinase that senses 
a specific environmental stimulus and a cognate response regulator that mediates a cellular 
response, usually by activating and/or repressing differentially expressed genes.
Housekeeping sigma factor
A sigma factor that binds to the catalytic core of RNA polymerase and recognizes promoters 
of genes required for core bacterial cell functions, such as maintenance and metabolism.
Alternative sigma factor
A sigma factor that binds to the catalytic core of RNA polymerase, displacing the 
housekeeping sigma factor, re-directing transcription towards genes required to respond to a 
particular environmental stimulus, condition, or stress.
Heat-shock response
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The bacterial cell’s response to a sudden increase in temperature, involving differential gene 
expression regulated through the alternative sigma factor σ32.
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Key points
• Pathogenic treponemes are clonal, uncultivatable, highly invasive 
bacteria that cause venereal syphilis, yaws, endemic syphilis, and pinta
—multi-stage, infections that have many similarities but can be 
differentiated based on clinical, epidemiologic, and geographic criteria. 
Only Treponema pallidum subsp. pallidum is transmitted by sexual 
activity.
• Key to the syphilis spirochete’s capacity for immune evasion and thus 
‘stealth pathogenicity’ is its unusual outer membrane, which lacks 
lipopolysaccharide and contains an extremely low density of integral 
membrane proteins and a paucity of surface-exposed lipoproteins. 
Production of opsonic antibodies against low abundance surface 
antigenic targets is believed to be essential for control of syphilitic 
infection.
• In recent years, considerable progress has been made in defining the 
syphilis spirochete’s repertoire of β-barrel-forming rare outer 
membrane proteins and the mechanisms by which the bacterium seems 
to limit exposure of surface molecules to the host’s antibody-mediated 
defenses.
• During the course of genomic reduction, T. pallidum has undergone 
adaptations that enable it to acquire all of its required nutrients from its 
obligate human host and optimize their usage within various niches, 
while coping with exogenous and endogenous stress.
• The T. pallidum genome encodes several alternative sigma factors and 
other regulatory molecules/pathways that collectively point to a 
previously unsuspected capacity to intricately regulate gene expression 
within diverse microenvironments.
• Comparative genomics has enabled investigators to identify ‘hot spots’ 
for sequence variation that likely explain differences in virulence 
potential and tissue tropisms among the pathogenic treponemes; many 
of these are located in proteins known or predicted to reside at the host-
pathogen interface.
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Figure 1. Morphology and cell envelope architecture of T. pallidum, the stealth pathogen
A. Darkfield micrograph showing the flat wave morphology of T. pallidum. Asterisks and 
arrowhead indicate segments oriented 90 degrees from each other (with permission from 
Reference 15). B. Top view of a surface-rendered model of T. pallidum generated from 
cryoelectron tomograms showing the outer and cytoplasmic membranes (transparent 
yellow), flagellar motors (basal bodies, dark lavender), flagellar filaments (light lavender), 
cytoplasmic filaments (orange), cap (green), and cone (pink) (with permission from 
Reference 15). C. Freeze-fracture electron microscopy reveals scarce particles (integral 
membrane proteins) within the T. pallidum outer membrane. Convex and concave leaflets of 
the outer membrane are indicated; arrowheads indicate particles in the two leaflets (with 
permission from Reference 155). D. Scanning probe microscopy reveals rare particles on the 
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T. pallidum surface (arrows), often located on the bulge in the outer membrane created by 
the underlying periplasmic flagella (asterisks) (with permission from Reference 91). E. 
Model for the molecular architecture of the T. pallidum cell envelope. Shown in the outer 
membrane are BamA (TP0326)59,64, a generic bipartite (that is, full-length) Tpr attached by 
its N-terminal portion to the peptidoglycan 59–61, a generic non-Tpr β-barrel, and TP0453 
(p30.5), a structurally characterized lipoprotein attached to the outer membrane inner 
leaflet156. Tprs, such as TprF, lacking the MOSPC β-barrel forming domain, are located in 
the periplasm59. Substrates present in high concentration in the extracellular milieu probably 
traverse the outer membrane by simple diffusion through porins, such as TprC. Prototypic 
ABC-like transporters use a periplasmic substrate-binding protein (SBP), typically 
lipoproteins, and components with transmembrane and ATP-binding domains. The energy 
coupling factor (ECF)-type ABC transporters uses a transmembrane ligand-binding protein 
in place of a separate periplasmic SBP. To substitute for ATP hydrolysis, the symporters use 
a transmembrane permease that relies on energy from a chemiosmotic or electrochemical 
gradient that may be generated by the Rnf complex. The tripartite ATP-independent 
periplasmic (TRAP) transporters also lack ATP-binding modules and use transmembrane 
electrochemical gradients, but they are more complex. T. pallidum seems to have evolved a 
variation on the TRAP theme by also using an additional periplasmic component protein 
(TatT (TP0956)) containing a tetratricopeptide repeat (TPR) motif, giving rise to a newly 
described system denoted as a TPR protein-associated TRAP transporter (TPAT). The TPR 
protein TatT likely associates with the SBP TatP (TP0957) in a heterohexameric fashion to 
carry out ligand binding and uptake; structural analyses suggest that this complex may 
accommodate a chain-like hydrophobic molecule(s), such as a long-chain fatty acid(s). 
Uptake likely is facilitated by a putative membrane permease (TatQ-M (TP0958)) of the 
TPAT system101,102. F. Cryotomographic section of T. pallidum near the cell end showing 
the peptidoglycan layer (arrowheads) midway between the outer membrane and cytoplasmic 
membrane (with permission from Reference 15). G. Cryotomographic section of T. pallidum 
showing chemoreceptor arrays (arrows, with permission from Reference 91). H. 
Cryotomographic slice showing the cone-shaped structure at T. pallidum cell ends (with 
permission from Reference 15) along with darkfield micrograph of T. pallidum stably 
attached via its tip to the surface of a trophoblast cell. White arrowheads indicate fine fibers 
between the cone and the outer membrane.
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Figure 2. Energy generation, amino acid biosynthesis, and regeneration of NAD+ in T. pallidum
T. pallidum’s glycolytic and pyruvate-to-acetate fermentation pathways are coupled to a 
putative Rnf pump, resulting in production of ATP by an ATP synthase; 
phosphoenolpyruvate (PEP) from glycolysis can be further metabolized to amino acids via 
PEP carboxykinase (PEP-CK). Metabolites, enzymes, and cofactors are shown in green, red, 
and blue, respectively. Abbreviations for enzymes are as follows: PPFK, 
phosphofructokinase; Nox, NADH oxidase; PPDK, pyruvate phosphate dikinase; OAD, 
oxaloacetate decarboxylase; TpaaT, aspartate aminotransferase; AsnA, asparagine 
synthetase; LDH, D-lactate dehydrogenase; PFOR, pyruvate-flavodoxin oxidoreductase; Pta, 
phosphate acetyl transferase; AckA, acetate kinase. Abbreviations for compounds/
metabolites are as follows: Fru-6-P, fructose 6-phosphate; Fru-1, 6-P2, fructose 1, 6-
bisphosphate; Pi, inorganic phosphate; PPi, inorganic pyrophosphate; CoA, coenzyme A; 
Acetyl-P; acetyl phosphate; RNF, a putative chemiosmotic pump with similarities to the 
Rhodobacter nitrogen fixation complex; Flavodoxinox and Flavodoxinred, oxidized and 
reduced forms of flavodoxin.
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Figure 3. Proposed pathways for control of alternative sigma factors in T. pallidum
A. σE cell envelope stress responses in T. pallidum and E. coli. Binding of misfolded OMPs 
to the PDZ domain of DegS (TP0773) initiates transduction of the stress signal across the 
cytoplasmic membrane. T. pallidum lacks a recognizable ortholog for RseB, a negative 
regulator that binds to RseA and protects it from DegS-mediated cleavage. B. σ54 (RpoN)-
dependent gene expression. T. pallidum contains two enhancer binding proteins, the NtrC-
like TP0519 and the NorR-like TP0082. Because TP0519 lacks a cognate histidine kinase, 
phosphorylation of TP0519 may occur through an acetyl-phosphate donor. Activation of 
TP0082 is predicted to occur following the binding of a small molecule to its GAF domain. 
tpF1 (tp1038), encoding a bacterioferritin, and tp1012, encoding an RpoS-like sigma factor, 
are predicted to be transcribed by σ54.
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Figure 4. Domain architecture of the T. pallidum repeat (Tpr) family of proteins Tprs in T. 
pertenue (TPE) and T. pallidum (TPA) strains
The Tprs are divided into three subfamilies based on sequence relatedness; within 
subfamilies I and II, members are closely related to each other, whereas members of 
subfamily III are heterogeneous52,63. Full-length Tprs consist of: (i) a variable extreme N-
terminal stretch (~50 amino acids); (ii) MOSPN, a conserved N-terminal domain related to 
the corresponding domain in the N-terminus of the major outer sheath protein (MOSP) of T. 
denticola; (iii) a variable central region; and (iv) MOSPC, a conserved C-terminal β-forming 
domain related to the corresponding domain in T. denticola MOSP. The thin yellow lines 
denote amino acid variation in TPE paralogs relative to the corresponding paralogs in the 
TPA Nichols strain. Shown in umber are insertions in the MOSPC domains of TprG and 
TprJ relative to the corresponding paralog in the TPA Nichols reference strain. The central 
domain of TprJ in TPE contains sequences derived from the corresponding region of TprG. 
TprL in the TPA Nichols strain contains an extended variable N-terminal stretch. In TPE, 
TprA and TprF are full-length, bipartite proteins. The blue and red lines, respectively, are 
used to indicate sequence variation in TprD2 and TprI relative to TprC/D in TPA Nichols. 
With the exception of the Sea81-4 TPA strain, TprA is truncated, lacking the MOSPC 
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domain; TprF is truncated in all TPA strains. TprK is not shown because of its 
hypervariability.
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Table 1
Candidate proteins potentially responsible for phenotypic differences between T. pallidum subsp. pertenue 
(TPE) and subsp. pallidum (TPA) strains*
Protein Name Predicted function and comments References
TP0009 TprA Potential porin (when C-terminal domain is present) 59–61
TP0117** TprC Porin 59,60
TP0131** TprD Porin 59,60
TP0133 HP, immunogenic protein 157,158
TP0134 HP, putative outer membrane protein Annotation
TP0136** Fibronectin-binding protein 76,77
TP0314 HP, not annotated in TPA Annotation
TP0316 TprF Potential porin (when C-terminal domain is present) 59,60
TP0326** BamA Originally Tp92; Outer membrane biogenesis 58,64,65
TP0433** Arp Acidic repeat protein, function unknown Annotation
TP0462** HP, putative lipoprotein Annotation
TP0488** Mcp2-1 Methyl-accepting chemotaxis protein Annotation
TP0548** Predicted rare outer membrane protein 57
TP0619** HP Annotation
TP0620** TprI Porin 59,60
TP0621 TprJ Potential porin 59–61
TP0733 HP, outer membrane protein Annotation
TP0858 Predicted outer membrane protein 57
TP0865** HP, putative outer membrane protein Annotation
TP0897** TprK Conflicting evidence regarding status as a bona fide outer membrane protein (see text) 52,56,61
TP0968 HP Annotation
TP1031** TprL Potential porin 59–61
*
Proteins with six or more amino acid replacements and/or major sequence differences between TPE and TPA strains according to Čejková et 
al.143
**Candidates for phenotypic differences between TPA strains (Nichols, DAL-1, Chicago, SS14, and MexicoA).
HP, hypothetical protein.
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